Oculis Holding AG (OCS) Equity Ratio (2021 - 2025)
Oculis Holding AG (OCS) recorded quarterly Equity Ratio of 248.72 in Q4 2025, down 32.98% quarter-over-quarter from 371.1 in Q4 2024, and down 32.98% on a YoY basis from 371.1 in Q4 2024.
Oculis Holding AG (OCS) Equity Ratio (2021 - 2025) Analysis & Trends
Oculis Holding AG's Equity Ratio history runs 5 years deep, the most recent figure standing at 248.72 for Q4 2025.
- In Q4 2025, Equity Ratio fell 32.98% year-over-year to 248.72; the TTM figure through Dec 2025 stood at 248.72 (down 32.98% YoY), while the FY2025 annual figure was 248.72, down 32.98% from the prior year.
- Equity Ratio was 248.72 for Q4 2025 at Oculis Holding AG, down from 371.1 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 371.1 in Q4 2024 to a low of 2.64 in Q4 2022.
- Historically, Equity Ratio has averaged 187.32 across 5 years, with a median of 248.72 in 2025.
- The sharpest annual moves came in 2022 and 2023: Equity Ratio slumped 151.78% in 2022, then soared 12221.1% in 2023.
- A 5-year view of Equity Ratio shows it stood at 1.05 in 2021, then plunged by 151.78% to 2.64 in 2022, then soared by 12221.1% to 320.5 in 2023, then increased by 15.79% to 371.1 in 2024, then tumbled by 32.98% to 248.72 in 2025.
- The last three Equity Ratio figures came in at 248.72 (Q4 2025), 371.1 (Q4 2024), and 320.5 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 191.07 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 0.04 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.42 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 0.79 |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 248.72 |
| Dec 31, 2024 | 371.10 |
| Dec 31, 2023 | 320.50 |
| Dec 31, 2022 | -2.64 |
| Dec 31, 2021 | -1.05 |